Stanford University
Showing 41-50 of 268 Results
-
Ehsan Adeli
Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Public Mental Health and Populations Sciences)
Current Research and Scholarly InterestsMy research lies in the intersection of Machine Learning, Computer Vision, Healthcare, and Computational Neuroscience.
-
Steven Adelsheim
Clinical Professor, Psychiatry and Behavioral Sciences
BioSteven Adelsheim, MD is a child/adolescent and adult psychiatrist who works to support community behavioral health partnerships locally, regionally, at the state level and nationally. He is the Director of the Stanford Center for Youth Mental Health and Wellbeing in the Department of Psychiatry. Dr. Adelsheim has partnered in developing statewide mental health policy and systems, including those focused on school mental health, telebehavioral health, tribal behavioral health programs, and suicide prevention. For many years Dr. Adelsheim has been developing and implementing early detection/intervention programs for young people in school-based and primary care settings, including programs for depression, anxiety, prodromal symptoms of psychosis, and first episodes of psychosis. Dr. Adelsheim is also involved in the implementation of integrated behavioral health care models in primary care settings as well as the use of media to decrease stigma surrounding mental health issues. He is currently leading the US effort to implement the headspace model of mental health early intervention for young people ages 12-25 based in Australia. Dr. Adelsheim also leads the national clinical network for early psychosis programs called PEPPNET.
-
John R. Adler, MD
The Dorothy and Thye King Chan Professor in Neurosurgery, Emeritus
Current Research and Scholarly InterestsThe development and implementation of computerized, image-guided surgical tools to be used during minimally invasive brain operations. The clinical outcome of new technologies, and in particular the application of radiosurgery, for the treatment of brain tumors. The creation of new radiosurgical techniques for a wide array of brain and spine disorders.
-
Sarah Adler
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsI am interested in the design and delivery of clinical care using, data and technology. I have focused on disordered eating behaviors and obesity.
-
Shehla Admani, MD
Clinical Associate Professor, Dermatology
BioShehla Admani is a Clinical Assistant Professor of Dermatology at Stanford University, School of Medicine. Dr. Admani completed her dermatology residency at the University California, San Diego where she served as chief resident during her final year. She then completed her pediatric dermatology fellowship at Stanford University, School of Medicine and has stayed on as faculty since that time. She is board certified in dermatology and pediatric dermatology. Dr. Admani’s academic interests include pediatric dermatology, vulvar dermatology and teledermatology.
-
Bruce T. Adornato
Adjunct Clinical Professor, Neurology & Neurological Sciences
BioDr. Adornato joined the Department of Neurology as Voluntary Clinical Faculty in 1978, (subsequently Adjunct Clinical Faculty) and has served as Director of the Neuromuscular Laboratory from 1978 until 1983, performing and interpreting nerve and muscle biopsies as well as serving as attending physician directing residents and medical students in the diagnosis and care of his private patients admitted to Stanford Hospital. Since 1986, he has been attending physician at the Palo Alto VA Hospital, directing Stanford Neurology residents and medical students in the care of veterans. He has published 69 peer reviewed papers and a number of book chapters in the field of neurology. He is currently the medical officer of a silicon valley startup exploring mobility devices for the neurologically impaired.
-
Ranjana Advani
Saul A. Rosenberg, MD, Professor of Lymphoma
Current Research and Scholarly InterestsClinical investigation in Hodgkin's disease, non-Hodgkin's Lymphomas and cutaneous lymphomas. Experimental therapeutics with novel chemotherapy and biologically targeted therapies.
The research program is highly collaborative with radiation oncology, industry, pathology and dermatology.
